LLY Stock Hits All-Time High — CVS Coverage Boost For Zepbound May Be Driving Gains

CVS Health’s decision to expand formulary coverage for key GLP-1 therapies marks a boost for Eli Lilly's obesity drug ...
People

The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 Charlotte Phillipp is a Writer-Reporter at PEOPLE.
CNBC

Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply

Eli Lilly released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to increase access for patients without insurance coverage for the highly popular ...